Showing results (331-340 of 556) with videos related to
Sort By:
Pageof 56
Journal of the American Heart Association|August 5, 2022
Risk of Sudden Death in a General Unbiased Epidemiological Cohort of SarcoidosisC Anwar A Chahal, Peter A Brady, Leslie T Cooper, et al.Heliyon|July 17, 2023
Cardiac imaging for the prediction of sudden cardiac arrest in patients with heart failureFrancesca De Lio, Alessandro Andreis, Giulia De Lio, et al.Internal and Emergency Medicine|July 20, 2018
Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured termAntonio Brucato, Massimo Imazio, Paul C Cremer, et al.Frontiers in Cardiovascular Medicine|March 11, 2024
The inflammatory spectrum of cardiomyopathiesNicolas Musigk, Phillip Suwalski, Ainoosh Golpour, et al.The New England Journal of Medicine|September 3, 2013
A randomized trial of colchicine for acute pericarditisMassimo Imazio, Antonio Brucato, Roberto Cemin, et al.The American Journal of Cardiology|July 30, 2011
Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndromeMassimo Imazio, Antonio Brucato, Maria Elena Rovere, et al.Journal of Vascular Surgery|January 18, 2006
Takayasu's arteritis: operative results and influence of disease activityCharles E Fields, Thomas C Bower, Leslie T Cooper, et al.European Journal of Heart Failure|November 1, 2018
Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centresLynn A Fussner, Erin Karlstedt, David O Hodge, et al.American Heart Journal|September 1, 2020
RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditisAllan L Klein, Massimo Imazio, Antonio Brucato, et al.International Journal of Cardiology|April 20, 2021
Identification of a novel presumed cardiac sarcoidosis category for patients at high risk of diseaseAndrew N Rosenbaum, Nikhil Kolluri, Mohamed Y Elwazir, et al.Pageof 56